Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 0 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 2 analysts offering 12 month price targets for Biotalys NV have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a 141.94% increase from the last price of 3.10.
High | 190.3% | 9.00 |
Med | 141.9% | 7.50 |
Low | 93.5% | 6.00 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in EUR
Average growth rate | +22.44% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +73,809.82% |
More ▼